Form 8-K - Current report:
SEC Accession No. 0001193125-26-202609
Filing Date
2026-05-04
Accepted
2026-05-04 08:00:06
Documents
11
Period of Report
2026-05-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d150234d8k.htm   iXBRL 8-K 48846
  Complete submission text file 0001193125-26-202609.txt   166661

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mirm-20260504.xsd EX-101.SCH 3176
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20260504_lab.xml EX-101.LAB 17991
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20260504_pre.xml EX-101.PRE 11258
14 EXTRACTED XBRL INSTANCE DOCUMENT d150234d8k_htm.xml XML 3655
Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 26934680
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)